Top Industry Leaders in the Thoracic Outlet Syndrome Market
Latest Thoracic Outlet Syndrome Companies Updates:
Medtronic receives FDA approval for its Intellis™ neurostimulation system for treating chronic neuropathic pain associated with TOS, offering a non-surgical option for pain management.
Abbott announces positive early data from a Phase 2 clinical trial of its DRG stimulator for treating nerve compression in TOS, demonstrating potential for improved nerve function and pain relief.
Vertos Medical Group secures additional funding to expand its clinical trial of the VERTIGO™ nerve decompression system for treating TOS, aiming to demonstrate its effectiveness in reducing symptoms and improving functional outcomes.
The Thoracic Outlet Syndrome Foundation (TOS Foundation) collaborates with medical institutions and researchers to advance TOS research and develop evidence-based treatment guidelines.
List of Thoracic Outlet Syndrome Key companies in the market:
- Piramal Critical Care
- Pfizer Inc.
- Validus Pharmaceuticals LLC
- GlaxoSmithKline plc
- Novartis AG
- Sanofi
- Abbott
- Bristol-Myers Squibb Company